{
    "paper_id": "8d23f8e9397fe2479a953361f10143da6c8f5036",
    "metadata": {
        "title": "VIROPORIN ACTIVITY OF SARS-CoV E PROTEIN",
        "authors": [
            {
                "first": "Ying",
                "middle": [],
                "last": "Liao",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "James",
                "middle": [
                    "P"
                ],
                "last": "Tam",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ding",
                "middle": [
                    "X"
                ],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "INTRODUCTION",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "HB assay and construction of plasmids: HeLa cells were transfected with appropriate plasmids, pretreated with different concentrations of HB (Sigma), and labeled with [ 35 S] methionine/cysteine (Amersham). Cells were incubated in the presence or absence of HB, harvested and lysed. Total proteins were immunoprecipitated with appropriate antibodies, and analyzed by SDS 15% polyacrylamide gel electrophoresis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Plasmids pFlagE and pFlagN was constructed by cloning an EcoRV-and EcoRIdigested PCR fragments into EcoRV-and EcoRI-digested pFlag vector. The Flag-tag was fused to the N-terminal end of the E protein. Mutations were introduced into the E gene by two rounds of PCR and confirmed by automated sequencing. The mutant constructs included in this study are summarized in Fig. 1. ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 367,
                    "end": 374,
                    "text": "Fig. 1.",
                    "ref_id": null
                }
            ],
            "section": "Abstract"
        },
        {
            "text": "RESULTS",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Alteration of Membrane Permeability by the Expression of E Protein",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "To test if E protein can alter the membrane permeability of mammalian cells, the Flag-tagged E protein was expressed in HeLa cells and HB assay was performed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Viroporins are integral membrane proteins encoded by viruses that contain a highly hydrophobic domain able to form an amphipathic \u03b1-helix and tend to oligomerize to form a hydrophilic pore after insertion into cellular membranes. They affect the vesicle system of host cells, glycoprotein trafficking, and membrane permeability, leading to the promotion of viral particle release. 1 In this study, we showed that SARS-CoV E protein could obviously enhance membrane permeability to hygromycin B (HB), a protein synthesis inhibitor, upon expression in mammalian cells. This activity was shown to be associated with the transmembrane domain of E protein. protein and some other cellular proteins (lane 1). In cells treated with 1 and 2 mM of HB, no obvious detection of the E protein and other cellular proteins was obtained (Fig. 2,  lanes 2 and 3) . However, as a negative control, in cells transfected with the SARS-CoV N protein, a similar amount of the N protein was detected in cells both treated and untreated with HB (Fig. 2 , lanes 4-6). ",
            "cite_spans": [
                {
                    "start": 381,
                    "end": 382,
                    "text": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [
                {
                    "start": 822,
                    "end": 846,
                    "text": "(Fig. 2,  lanes 2 and 3)",
                    "ref_id": "FIGREF2"
                },
                {
                    "start": 1022,
                    "end": 1029,
                    "text": "(Fig. 2",
                    "ref_id": "FIGREF2"
                }
            ],
            "section": ""
        },
        {
            "text": "Extracts prepared from cells without treatment with HB showed detection of the E isoforms may be derived from post-translational modifications of E protein.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "200"
        },
        {
            "text": "SARS-CoV E protein contains three cysteine residues at amino acid positions 40, 43, and 44, respectively. These residues are located 3-7 amino acids downstream of the constructs showed specific detection of three isoforms of E protein migrating at a range of molecular masses from 14 to 18 kDa under reducing conditions (Fig. 3a) . These In the membrane permeability assay shown in Fig. 3b , SARS-CoV N protein was cotransfected into HeLa cells together with wild-type and mutant E proteins. Expression of wild-type and mutant E protein showed that similar levels of inhibition of protein synthesis by HB were obtained (Fig. 3b ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 320,
                    "end": 329,
                    "text": "(Fig. 3a)",
                    "ref_id": "FIGREF3"
                },
                {
                    "start": 382,
                    "end": 389,
                    "text": "Fig. 3b",
                    "ref_id": "FIGREF4"
                },
                {
                    "start": 619,
                    "end": 627,
                    "text": "(Fig. 3b",
                    "ref_id": "FIGREF4"
                }
            ],
            "section": "200"
        },
        {
            "text": "SARS-CoV E protein contains a long putative transmembrane domain of 29 amino acid residues. 2 This domain may be involved in the formation of ion channel by oligomerization. 3 Mutations of the putative transmembrane domain were carried out to study its functional roles. Four mutants, Em1, Em2, Em3, and Em4, were made by mutation of 3-7 leucine/valine residues to charged amino acid residues in the transmembrane domain (Fig. 1) . Em5 was constructed based on the molecular simulation studies showing that N15 residue may be essential for oligomerization of the protein (Fig.  1) . Em6 was made by combination of Em4 and C40/43/44-A (Fig. 1) . Expression of these mutants showed the detection of polypeptides with apparent molecular masses ranging from 10 to 18 kDa (Fig. 4a) . In the membrane permeability assay shown in Fig. 4b , cells expressing Em1, Em2, and Em5 exhibited a similar degree of inhibition of host protein synthesis as wild-type E protein (Fig 4b, lanes 1-9 and 16-18) . In cells expressing Em3 and Em4, much less inhibition of protein synthesis by HB was observed compared with wild-type E protein (Fig. 4b, lanes 10-15) . No inhibition of protein synthesis was observed in cells expressing Em6 (Fig. 4b, lanes 19-21) . ",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 175,
                    "text": "3",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [
                {
                    "start": 421,
                    "end": 429,
                    "text": "(Fig. 1)",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 571,
                    "end": 580,
                    "text": "(Fig.  1)",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 634,
                    "end": 642,
                    "text": "(Fig. 1)",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 767,
                    "end": 776,
                    "text": "(Fig. 4a)",
                    "ref_id": "FIGREF6"
                },
                {
                    "start": 823,
                    "end": 830,
                    "text": "Fig. 4b",
                    "ref_id": "FIGREF7"
                },
                {
                    "start": 958,
                    "end": 987,
                    "text": "(Fig 4b, lanes 1-9 and 16-18)",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1118,
                    "end": 1140,
                    "text": "(Fig. 4b, lanes 10-15)",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1215,
                    "end": 1237,
                    "text": "(Fig. 4b, lanes 19-21)",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "Mutational Analysis of the Transmembrane Domain of E Protein"
        },
        {
            "text": "SARS-CoV E protein is associated with the transmembrane domain. The C40 and C44 of the E protein were previously shown to play important roles in modification of membrane permeability in bacterial cells, 4 but no obvious effect was observed in mammalian cells SAR-CoV E protein could form cation-selective ion channels further demonstrated E protein is a viroporin. 5 It was also reported that MHV E protein could enhance membrane in this study. Only after combining mutation of the transmembrane domain and three",
            "cite_spans": [
                {
                    "start": 366,
                    "end": 367,
                    "text": "5",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "DISCUSSION AND CONCLUSION"
        },
        {
            "text": "In this study, we demonstrate that the membrane permeabilizing activity of cysteine residues was the membrane-permeabilizing activity of E protein totally disrupted. It suggests that these cysteine residues may play certain roles in the membrane association and membrane-permeabilizing activities of the E protein. A recent report that showed would abrogate viral infectivity, rendering E protein suitable targets for the development coronaviruses is endowed with viroporin activity. Disruption of the function of viroporins permeability in bacterial cells. These results suggest that E protein from different",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION AND CONCLUSION"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "The ion channels coded by viruses",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ciampor",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Acta Microbiol. Immunol. Hung",
            "volume": "50",
            "issn": "",
            "pages": "433--442",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "A highly unusual palindromic transmembrane helical hairpin formed by SARS coronavirus E protein",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Arbely",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J. Mol. Biol",
            "volume": "341",
            "issn": "",
            "pages": "769--779",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "The transmembrane oligomers of coronavirus protein E",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Torres",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Biophys. J",
            "volume": "88",
            "issn": "",
            "pages": "1283--1290",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lescar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Tam",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "X"
                    ],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Biochem. Biophys. Res. Commun",
            "volume": "325",
            "issn": "",
            "pages": "374--380",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "SARS coronavirus E protein forms cation-selective ion channels",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mckinlay",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gage",
                    "suffix": ""
                },
                {
                    "first": "Ewart",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Virology",
            "volume": "330",
            "issn": "",
            "pages": "322--331",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Viroporin activity of murine hepatitis virus E protein",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Madan",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "FEBS Lett",
            "volume": "579",
            "issn": "",
            "pages": "3607--3612",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Amino acid sequence of wild-type and mutant SARS-CoV E protein. The putative transmembrane domain is underlined.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "transmembrane domain(Fig. 1). Mutations of these residues to alanine were made to generate seven mutants (C40-A, C43-A, C44-A, C43/44-A, C40/44-A, C40/43-A and C40/43/44-A)(Fig. 1). Western blot of cells expressing wild-type and most mutant",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Modification of HeLa cells membrane permeability by SARS-CoV E protein.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Expression",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Entry of Hygromycin B into HeLa cells expressing wild type and cysteine mutant E proteins. 1: E+N; 2: C40-A+N; 3: C43-A+N; 4:C44A+N; 5: C43/44-A+N; 6: C40/44-A+N; 7: C40/43-A+N; 8: C40/43/44-A+N.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "201 VIROPORIN ACTIVITY OF SARS-CoV E PROTEINY. LIAO ET AL.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Expression of the wild-type and transmembrane domain mutant E proteins in Hela cells.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "Entry of Hygromycin B into Hela cells expressing wild-type and transmembrane domain mutant E proteins.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}